Why the study?
Does primary percutaneous coronary intervention in very elderly patients (>80 years) with STEMI result in worse in-hospital outcomes and 1-year survival compared to patients aged 65-69 years?
Cohort (n=284)
No
Does primary percutaneous coronary intervention in very elderly patients (>80 years) with STEMI result in worse in-hospital outcomes and 1-year survival compared to patients aged 65-69 years?
Very elderly patients (>80 years) undergoing pPCI for STEMI experience more complications and reduced overall survival compared to younger patients, highlighting the need for careful risk-benefit assessment.
May warrant cautious risk-benefit assessment before primary PCI in octogenarians with STEMI; leaves open whether intervention improves net outcomes versus alternatives.
The proportion of individuals >80 years of age constitute an increasing proportion of patients who present with ST-segment elevation myocardial infarction (STEMI). The objective of this study is to evaluate in-hospital outcomes and 1-year survival of very elderly patients who present with an STEMI and undergo primary percutaneous coronary intervention (pPCI). Between 2009 and 2015, individuals >80 years of age (very elderly patients) with an STEMI presenting at a single tertiary Canadian care center were included in the study. A random sample of 100 individuals aged 65 to 69 years over the same time period were selected as a control group. A total of 284 patients were included in the study population including 100 controls, 164 octogenarians, and 20 nonagenarians. Of total, 1661 pPCIs occurred during this study period with the very elderly population (>80 years) comprising 11.1% of the total pPCIs. Compared with controls, individuals aged >80 are more likely to have a delay in treatment with increased rates of bleeding, acute kidney injury, rehospitalization, and a trend toward longer hospital stays following pPCI for STEMI. Although in-hospital and 1-year mortality were similar between both cohorts >80 years of age with STEMI, their overall survival was reduced compared with controls.
No takes yet. Share an insight, caveat, or question.
Sharma et al. (2017) conducted a cohort in ST-segment elevation myocardial infarction (STEMI) (n=284). Primary percutaneous coronary intervention (pPCI) vs. Patients aged 65 to 69 years was evaluated on In-hospital outcomes and 1-year survival.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: